Royce & Associates’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-42,000
Closed -$1.17M – 1249
2017
Q2
$1.17M Hold
42,000
– – 0.01% 935
2017
Q1
$1.04M Buy
42,000
+16,000
+62% +$390K 0.01% 974
2016
Q4
$633K Buy
+26,000
New +$620K ﹤0.01% 989
2014
Q2
– Sell
-574,000
Closed -$10M – 1434
2014
Q1
$10M Sell
574,000
-309,000
-35% -$5.21M 0.03% 674
2013
Q4
$16.2M Sell
883,000
-424,000
-32% -$7.92M 0.05% 479
2013
Q3
$24.7M Sell
1,307,000
-123,000
-9% -$2.45M 0.07% 312
2013
Q2
$27.5M Buy
+1,430,000
New +$27.2M 0.09% 279

Other funds holding G

Royce & Associates's G Position: Q3 2017 in Review

Royce & Associates sold out of Genpact (G) in Q3 2017, closing a stake of 42,000 shares — an estimated $1.17M sold.

Royce & Associates first reported a position in G in Q2 2013 and held it in 7 quarters. The position peaked at $27.5M in Q2 2013. 224 funds tracked by Wall St. Rank hold G as of Q3 2017.

  • Royce & Associates reported no remaining Genpact position as of Q3 2017 after selling out during the quarter.
  • Royce & Associates sold 42,000 Genpact shares in Q3 2017, an estimated $1.17M.
  • Royce & Associates first reported a position in Genpact in Q2 2013 and held it in 7 quarters.
  • Royce & Associates's Genpact position peaked at $27.5M in Q2 2013.
  • 224 funds tracked by Wall St. Rank held Genpact as of Q3 2017.

Based on Royce & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.